Clinical Trial Update: Biomarkers for Post-COVID Conditions

View source ↗

Summary

A completed clinical trial investigating biomarkers for post-COVID conditions to better understand long-term effects of SARS-CoV-2 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Zealand University Hospital | Conditions: COVID-19, SARS-CoV-2 | Status: COMPLETED